Invokana Attorney | Law Firm Newswire

San Diego, CA (Law Firm Newswire) July 21, 2015 – Officials representing Health Canada, the department of the government of Canada responsible for national public health, announced recently that the agency would be investigating the safety of Invokana and similar medications, due to concerns that the Type 2 diabetes drugs may increase the risk of patients suffering ketoacidosis side effects. The Health Canada announcement comes on the heels of a May 2015 safety communication issued by the U.S. Food and Drug Administration (FDA), which warned of a possible connection between sodium-glucose cotransporter-2 (SGLT2) medications and diabetic ketoacidosis. For those that […]


Continue reading full article »